John Freund
QuietNamed in filings at Canal Capital PartnersOn the current fund
- Board seats filed
- 8
Named in filings at Canal Capital PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| SCG Jet Edge Holdings Limited Partnership | Manufacturing & industrials | November 2020 | None on file |
| TETRAPHASE PHARMACEUTICALS | Biotech & pharma | January 2020 | None on file |
| SUTRO BIOPHARMA | Biotech & pharma | May 2018 | Samsara Biocapital, SV Life Sciences, Virtuoso-mccarran |
| JUMP TECHNOLOGIES | Enterprise software | August 2016 | None on file |
| COLLEGIUM PHARMACEUTICAL | Biotech & pharma | March 2015 | None on file |
| Advion | Robotics & hardware | June 2014 | Aisling Capital |
| PROTEON THERAPEUTICS | Biotech & pharma | May 2014 | Abingworth Bioventures, MPM BioVentures |
| SI-BONE | Medical devices | April 2014 | Orbimed Asia Partners, Orbimed Genesis |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name John Freund on the board, based on 8 filed seats with a verified or cited source.